rheumatoid arthritis

Pfizer bags rheumatoid arthritis rights to new immunotherapy class through deal with Imcyse
Fierce Biotech
Thu, 02/4/21 - 10:41 am
Pfizer
Imcyse
rheumatoid arthritis
drug development
Aclaris MK2 bears fruit
EP Vantage
Tue, 01/19/21 - 09:17 pm
Aclaris
rheumatoid arthritis
clinical trials
ATI-450
Gilead downsizes multibillion-dollar deal once at center of CEO's rebuild
Bizjournals
Tue, 12/15/20 - 08:31 pm
Gilead Sciences
Galapagos
clinical trials
filgotinib
rheumatoid arthritis
inflammatory bowel disease
Gilead stops 3 filgotinib trials pending FDA feedback on faltering JAK1 inhibitor
Fierce Biotech
Thu, 10/29/20 - 12:07 pm
Gilead Sciences
filgotinib
FDA
rheumatoid arthritis
FDA rejects Gilead's would-be blockbuster filgotinib over toxicity concerns
Fierce Biotech
Wed, 08/19/20 - 09:23 am
Gilead Sciences
filgotinib
rheumatoid arthritis
FDA
clinical trials
5 FDA approval decisions to watch in the 3rd quarter
BioPharma Dive
Thu, 07/9/20 - 11:09 am
FDA
Gilead Sciences
filgotinib
rheumatoid arthritis
GSK
belantamab mafodotin
Multiple Myeloma
NS Pharma
viltolarsen
Duchenne Muscular Dystrophy
Amgen's Enbrel Patents to Be Upheld Through 2029
Motley Fool
Thu, 07/2/20 - 12:15 am
psoriasis
rheumatoid arthritis
Enbrel
Novartis
biosimilars
patents
Gilead shows durability of filgotinib ahead of face-off with AbbVie
Fierce Biotech
Thu, 06/4/20 - 11:00 am
Gilead Sciences
Galapagos
clinical trials
filgotinib
rheumatoid arthritis
Galapagos CEO talks next steps as coronavirus stalls the biotech's top drug
BioPharma Dive
Wed, 03/25/20 - 11:41 pm
Galapagos
Gilead Sciences
filgotinib
rheumatoid arthritis
FDA
COVID-19
Gilead gets ball rolling on JAKs game in Japan
Endpoints
Mon, 12/30/19 - 10:39 am
Gilead Sciences
Japan
filgotinib
Eisai
rheumatoid arthritis
As promised, Gilead and Galapagos file filgotinib to FDA and get a speedy review
Fierce Biotech
Fri, 12/20/19 - 12:29 pm
Gilead Sciences
FDA
filgotinib
Galapagos
rheumatoid arthritis
Amgen snags another Enbrel outcomes-based payment deal as it seeks to prop up aging blockbuster
Fierce Pharma
Wed, 12/4/19 - 11:18 pm
Amgen
Enbrel
Abarca
PBMs
rheumatoid arthritis
ICER says ‘marginal’ benefits for AbbVie’s new RA drug
Pharmaforum
Sat, 11/30/19 - 11:02 pm
ICER
AbbVie
Rinvoq
rheumatoid arthritis
biosimilars
ICER says AbbVie’s Rinvoq for RA may be cost-effective but still questions the value of JAK class
Fierce Pharma
Fri, 10/11/19 - 11:53 am
ICER
AbbVie
Rinvoq
rheumatoid arthritis
JAK inhibitors
Gilead, Galapagos share 52-week update on filgotinib
Fierce Biotech
Fri, 10/11/19 - 10:44 am
Gilead Sciences
Galapagos
filgotinib
clinical trials
rheumatoid arthritis
ICER pulls report blasting ‘marginal’ RA drugs, citing need to rethink its approach
Fierce Pharma
Wed, 10/2/19 - 11:53 am
ICER
JAK inhibitors
rheumatoid arthritis
AbbVie
Rinvoq
Pfizer
Xeljanz
Incyte
olumiant
Rheumatoid Arthritis Drug May Help Repair Heart After Heart Attacks
BioSpace
Fri, 09/20/19 - 10:43 pm
VentriGel
Ventrix
rheumatoid arthritis
heart attacks
Price, safety will test blockbuster billing for AbbVie's new arthritis drug
Biopharma Dive
Sat, 08/17/19 - 12:14 am
AbbVie
rheumatoid arthritis
drug pricing
Rinvoq
Rinvoq approval bolsters AbbVie's autoimmune portfolio
BioCentury
Fri, 08/16/19 - 11:54 pm
AbbVie
FDA
Rinvoq
Upadacitinib
rheumatoid arthritis
AbbVie's psoriasis launch Skyrizi hitting stride ahead of FDA's decision on upadacitinib
Fierce Pharma
Fri, 07/26/19 - 12:07 pm
AbbVie
Humira
biosimilars
Europe
psoriasis
rheumatoid arthritis
Skyrizi

Pages